Evommune, Inc. (EVMN)
Who owns Evommune, Inc. (EVMN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.5% of the shares are freely tradable; institutional investors hold 110.8%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| EQT Fund Management S.à r.l. | 13.69 | 4,929,633 | +0.0 | 03/31/2026 |
| RA Capital Management, LLC | 9.70 | 3,494,638 | +1.0 | 03/31/2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 5.35 | 1,926,943 | +0.0 | 03/31/2026 |
| Andera Partners | 5.27 | 1,897,362 | +0.0 | 03/31/2026 |
| RTW INVESTMENTS, LLC | 4.17 | 1,502,235 | +17.0 | 03/31/2026 |
| JPMorgan Chase & Co | 4.05 | 1,459,420 | +11.5 | 03/31/2026 |
| MPM Oncology Impact Management LP | 4.04 | 1,455,863 | +1,188.1 | 03/31/2026 |
| Nan Fung Group Holdings Ltd | 4.00 | 1,441,032 | +0.0 | 03/31/2026 |
| SymBiosis Capital Partners, LLC | 3.56 | 1,280,778 | +0.0 | 03/31/2026 |
| Eventide Asset Management, LLC | 3.36 | 1,209,129 | +25.8 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 7. Jul 2026 | Kirsch Arthur S | Director | Buy | 10,000 | 13.30 | 133,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.